What is CTSdatabase?

Paid Trial Alerts · Phoenix, Arizona · first-hand Phase 1

The second name that comes up when volunteers talk about screening databases. Like VCT, it exists to catch double enrollment — but it's a different company with a different member network, and the difference matters.

The short answer

CTSdatabase — Clinical Trial Subject Database — is a subject-verification registry that research sites can subscribe to. At screening, a member site checks your identifiers against the registry to see whether you're already enrolled in a study elsewhere, screened somewhere recently, or showing a pattern of enrolling more often than protocols allow. If the site you're screening at is a member, the check is part of your screening visit.

Why it exists

The same two reasons every subject registry exists: safety and data. Dosing in two studies at once can hurt you and muddies both sponsors' data. And research has a known "professional subject" problem — people who move between sites faster than washout windows allow, or who tune their answers to fit whatever study is enrolling. Sites that rely on self-reported history — behavioral and psychiatric studies especially — talk about this openly, which is where CTSdatabase gets discussed most. A registry turns "have you been in a study recently?" from an honor-system question into a checkable one, at least across its members.

What happens at your screening

• The check is disclosed in the screening consent paperwork at sites that use it.
• Staff submit identifiers; the registry returns participation flags from member sites — recent screens, recent enrollments.
• It is not a pull of your medical chart. For exactly which identifiers it takes and how long records live, the company's own documentation is the source — we describe what a volunteer experiences, and we don't paraphrase what we haven't verified.
• A flag usually means a timing conflict and a conversation, not a lifetime ban. A lie that a flag exposes is what clinics remember.

CTSdatabase vs VCT

Both are subject-verification networks; neither covers everyone. A clinic may use one, both, or neither, and a clean result in one network says nothing about the other. The practical consequence cuts both ways: you can't assume a study is "safe to overlap" because one database didn't flag you — and a clinic can't see studies done outside its network, which is why screeners still ask the question out loud. Treat the databases as enforcement, not as the rule itself: the rule is the protocol's washout window, and it binds you at every clinic, member or not.

What this means for you

• Disclose recent studies yourself. Volunteered conflicts are scheduling problems; discovered ones follow you.
• Keep your own record — study, clinic, last dose date. It answers the screener's question precisely and keeps you from guessing.
• Ask what the site uses. Coordinators will tell you whether their site checks a registry and which one. It costs nothing to know.